Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  AbbVie Inc    ABBV

ABBVIE INC (ABBV)

Delayed Quote. Delayed  - 02/11 03:59:59 pm
52.21 USD   -0.97%
10:44aDJShire Says Fourth-Quarter Sales Rose, Net Income Falls -- Update
09:18a ABBVIE : Launches Scholarship to Support Students Living with Rheuma..
08:16aDJShire Fourth-Quarter Sales Rose, Net Income Falls
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/05/2016 02/08/2016 02/09/2016 02/10/2016 02/11/2016 Date
53.12(c) 52.89(c) 53.48(c) 52.72(c) 52.21 Last
13 263 242 9 369 377 7 655 796 9 302 768 7 124 317 Volume
-6.41% -0.43% +1.12% -1.42% -0.97% Change
More quotes
Financials ($)
Sales 2016 26 005 M
EBIT 2016 11 225 M
Net income 2016 7 727 M
Debt 2016 18 362 M
Yield 2016 4,34%
Sales 2017 28 503 M
EBIT 2017 13 022 M
Net income 2017 9 213 M
Debt 2017 15 266 M
Yield 2017 4,72%
P/E ratio 2016 11,37
P/E ratio 2017 9,35
EV / Sales 2016 4,02x
EV / Sales 2017 3,56x
Capitalization 86 184 M
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company.It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products.The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis... 
Sector
Pharmaceuticals
Calendar
04/22Earnings Release
More about the company
Surperformance© ratings of AbbVie Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE INC
10:44aDJShire Says Fourth-Quarter Sales Rose, Net Income Falls -- Update
09:18a ABBVIE : Launches Scholarship to Support Students Living with Rheumatologic Dise..
08:16aDJShire Fourth-Quarter Sales Rose, Net Income Falls
08:10aDJSHIRE : Net Income Drops Sharply in Fourth Quarter
02/10 ABBVIE : Announces Positive Top-Line Results From Second Phase 3 Study Investiga..
02/10DJAbbVie Endometriosis Drug Trial Meets Endpoints
02/09DJPanel Recommends FDA Approval of Remicade Knockoff
02/09DJPanel Recommends FDA Approval of Remicade Knockoff
More news
Sector news : Specialty & Advanced Pharmaceuticals
10:44aDJShire Says Fourth-Quarter Sales Rose, Net Income Falls -- Update
10:41a BRISTOL MYERS SQUIBB : The 2015 Coast 2 Coast 4 Cancer Ride
10:23aDJEUROPE MARKETS : European Stocks Knocked To Lowest Since 2013 As Fear Selling Re..
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on ABBVIE INC 
2015A likely recovery
More Strategies
News from SeekingAlpha
02/10 MASSACHUSETTS-BASED PROTEOSTATIS THE : Early Stage And Stiff Competition Keeps U..
02/10 AbbVie's Elagolix successful in second late-stage study
02/09 Combination Of Infinity Pharma And AbbVie Could Be A Big Winner For The Adven..
02/09 Headlines Continue To Control Market Direction As Valuation Models Languish
02/08 The 3 Most Undervalued Dividend Growth Stocks We Follow


Comments 
Advertisement
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Technical analysis trends ABBVIE INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions